Jubilant Pharmova Reports Q1'FY27 Results; Revenue Grows 17% Amid Operational Challenges
Jubilant Pharmova Limited announced its financial and operational performance for the quarter ended June 30, 2026. The company reported a consolidated revenue of Rs. 2,229 Cr., marking 17% growth year-on-year (YoY). Total Income stood at Rs. 2,249 Cr., reflecting an 18% YoY increase. However, EBITDA decreased by 11% compared to the same period last year.The company’s board meeting approved the financial results for Q1'FY27. While revenue exhibited solid growth across all business segments, profitability metrics saw pressure. Reported PAT for the quarter was Rs. 56 Cr., a 45% decrease YoY from Rs. 103 Cr. in Q1'FY26.Segmental Performance Snapshot...